Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Graft vs Host Disease 1Cytopenia 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

fludarabine 2Melphalan 2Cyclophosphamide 2nicotinamide-beta-riboside 1fludarabine phosphate 1daratumumab 1X-Rays 1Whole-Body Irradiation 1Tacrolimus 1Stem Cell Transplantation 1Specimen Handling 1Mycophenolic Acid 1Mesna 1Influenza Vaccines 1Honey 1Hematopoietic Stem Cell Transplantation 1Emapalumab 1Busulfan 1Bone Marrow Transplantation 1Biopsy 111-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Anemia, Aplastic × Emapalumab × Clear all
NCT06430788 2025-12-17

A Study of Emapalumab for Pediatric Aplastic Anemia

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
35 enrolled
Classical hematology

Bone Marrow Failure Disorders, Cytopenia, Anemia, Aplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡